Quadrant Capital Group’s ChemoCentryx, Inc. CCXI Stock Holding History

Quadrant Capital Group’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-422	Closed	-$22K	–	2906
2022 Q3	$22K	Buy	422 +4	+1%	+$165	﹤0.01%	1500
2022 Q2	$10K	Hold	418	–	–	﹤0.01%	1693
2022 Q1	$10K	Hold	418	–	–	﹤0.01%	1668
2021 Q4	$15K	Hold	418	–	–	﹤0.01%	1460
2021 Q3	$7K	Buy	418 +402	+2,513%	+$6.26K	﹤0.01%	1776
2021 Q2	$0	Buy	16 +13	+433%	+$320	﹤0.01%	2631
2021 Q1	$0	Hold	3	–	–	﹤0.01%	2492
2020 Q4	$0	Sell	3 -3	-50%	-$172	﹤0.01%	2409
2020 Q3	$0	Sell	6 -8	-57%	-$431	﹤0.01%	2363
2020 Q2	$1K	Buy	+14	New	+$762	﹤0.01%	2176

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Quadrant Capital Group's CCXI Position: Q4 2022 in Review

Quadrant Capital Group sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 422 shares — an estimated $22K sold.

Quadrant Capital Group first reported a position in CCXI in Q2 2020 and held it in 10 quarters. The position peaked at $22K in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Quadrant Capital Group reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Quadrant Capital Group sold 422 ChemoCentryx, Inc. shares in Q4 2022, an estimated $22K.
Quadrant Capital Group first reported a position in ChemoCentryx, Inc. in Q2 2020 and held it in 10 quarters.
Quadrant Capital Group's ChemoCentryx, Inc. position peaked at $22K in Q3 2022.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Quadrant Capital Group's 13F filing for Q4 2022, filed 13 Feb 2023.